ADVERTISEMENT
Search

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Survey: One-third of consumers would ignore laws against buying from... Survey: One-third of consumers would ignore laws against buying from...

Survey: One-third of consumers would ignore laws against buying from...

0 32700

According to a new survey from the Alliance for Safe Online Pharmacies (ASOP) Global Foundation, almost half of Americans gamble with their lives to buy medication from online sources—even though the overwhelming majority of them operate illegally. That’s just one of the alarming findings from the organization’s 2021 survey of American perceptions and use of online pharmacies, which was commissioned from Abacus Data.

FDA alerts health professionals about varenicline recall FDA alerts health professionals about varenicline recall

FDA alerts health professionals about varenicline recall

0 43736

After Pfizer announced in late June that it was halting worldwide distribution of varenicline (Chantix) after detecting elevated levels of nitrosamines in the drug, FDA came out to alert patients and health professionals about the voluntary recall.

FDA approves higher dosage of naloxone nasal spray FDA approves higher dosage of naloxone nasal spray

FDA approves higher dosage of naloxone nasal spray

On April 30, FDA announced the approval of a higher dosage of naloxone hydrochloride nasal spray (Kloxxado—Hikma Pharmaceuticals) to treat...
0 19818
How to talk to patients about the J&J vaccine How to talk to patients about the J&J vaccine

How to talk to patients about the J&J vaccine

Patients will be coming to pharmacists with questions and concerns as the recommendation to suspend use of the Janssen (Johnson & Johnson,...
0 20099
12
ADVERTISEMENT